Predicting cognitive decline with amyloid-PET, plasma p-tau217, Aβ42/40, and p-tau217/Aβ42 in a community-based cohort - relevance for clinical trial enrollment
利用淀粉样蛋白PET、血浆p-tau217、Aβ42/40和p-tau217/Aβ42在社区人群中预测认知衰退——对临床试验入组的意义
期刊:Alzheimers & Dementia
影响因子:11.1
doi:10.1002/alz.70802
Bachmann, Dario; Wybitul, Maha; Buchmann, Andreas; Gericke, Christoph; Saake, Antje; Studer, Sandro; Rauen, Katrin; Gruber, Esmeralda; Blennow, Kaj; Zetterberg, Henrik; Nitsch, Roger M; Hock, Christoph; Treyer, Valerie; Gietl, Anton